Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2025-12-25 @ 2:40 AM
NCT ID:
NCT05675033
Eligibility Criteria:
Inclusion Criteria:
* Fully understood this study and voluntarily signed the informed consent form (ICF);
-≥ 18 years and ≤ 75 years old;
* ECOG score 0-1;
* Non-squamous NSCLC;
* stage IV;
* EGFR and ALK negative;
* Treatment-naive;
* According to RECIST1.1 criteria, there are measurable or evaluable lesions.
Exclusion Criteria:
* Tumor histology or cytology confirmed that it was associated with squamous cell carcinoma or small cell lung cancer;
* Patients with severe organ dysfunction were indicated by examination, Exclude subjects with any active, known or suspected autoimmune diseases;
* The estimated survival time is less than 3 months.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT05675033
Study Brief:
Protocol Section:
NCT05675033